5W, the AI Communications Firm, has released the Cannabis AI Visibility Index 2026, a ranking of the top 25 American cannabis brands by AI citation share across ChatGPT, Claude, Perplexity, and Google AI Overviews. The Index is the latest installment in 5W's AI Visibility Index Series, the agency's research franchise measuring how generative answer engines surface brands in consumer search.
The findings are based on more than 50 consumer-intent prompts. These prompts were run through major AI platforms in Q1 2026. The study tracks citations across U.S. multi-state operators, branded cannabis consumer products, CBD brands, dispensary aggregators and tech platforms, and ancillary services.
Top Findings from 5W Releases Cannabis AI Visibility Index 2026
- Curaleaf, Trulieve, and Green Thumb Industries together capture an estimated 17.5% of all cannabis-category AI citations.
- Cookies leads all branded consumer cannabis products by a wide margin.
- Charlotte's Web leads the CBD sub-category and has held the #1 position for five years.
- Leafly and Weedmaps each capture more aggregator citations than every individual MSO except Curaleaf.
- Approximately 28% of cannabis prompts produced answer engine refusals, hedges, or prominent disclaimers — the highest rate of any consumer category 5W has measured.
- The state-specific content multiplier in cannabis is approximately 2.8x — the largest signal effect 5W has measured in any tracked consumer category.
The release lands at the largest single citation reset cannabis has experienced since legalization began. President Trump signed an executive order on December 18, 2025 directing the rescheduling of cannabis to Schedule III.
Moreover, The DOJ and DEA finalized the order on April 23, 2026, placing FDA-approved marijuana products and state-licensed medical marijuana into Schedule III. A broader rescheduling hearing is schedule for June 29 through July 15, 2026.
"The brands winning citation share are the ones that build content addressing exactly the topics answer engines hedge on: state-specific legality, medical applications, dosing, drug interactions," said Ronn Torossian, Founder of 5W. "The brands waiting for federal clarity are losing citation surface every quarter to brands that built infrastructure during the volatility."
The takeaway
The cannabis industry is entering a new phase. AI visibility is now a core driver of brand discovery and trust. Also, brands that invest in structured, compliant, and state-specific content will gain share. Others risk falling behind.
The full report is available at https://www.5wpr.com/ai-visibility-index/cannabis-ai-visibility-index-2026/. The web version is free to read, and the PDF download is ungated.
